Evidence map›Paper›PMID 34515880›Full record

ArticleClinical and experimental medicine2022

Programmed cell death-ligand 1 (PD-L1)

Shoichi Kimura, Yumi Oshiro, Hiromi Iwasaki, Masanori Kadowaki, Yasuhito Mihashi, Toshifumi Sakata, Shigeto Kawauchi, Ziyao Wang, Yasushi Takamatsu, Morishige Takeshita

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shoichi KimuraGraduate School of Medical Sciences, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.
Yumi OshiroDepartment of Pathology, Matsuyama Red Cross Hospital, 1 Bunkyo-cho, Matsuyama, 7910000, Japan.
Hiromi IwasakiDepartment of Haematology, Clinical Research Centre, National Hospital Organization Kyushu Medical Centre, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 8108563, Japan.
Masanori KadowakiDepartment of Haematology, Clinical Research Centre, National Hospital Organization Kyushu Medical Centre, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 8108563, Japan.
Yasuhito MihashiDepartment of Otolaryngology, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.
Toshifumi SakataDepartment of Otolaryngology, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.
Shigeto KawauchiDepartment of Pathology, Clinical Research Centre, National Hospital Organization Kyushu Medical Centre, 1-8-1 Jigyohama, Chuo-ku, Fukuoka, 8108563, Japan.
Ziyao WangGraduate School of Medical Sciences, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.
Yasushi TakamatsuDivision of Medical Oncology, Haematology and Infectious Disease, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.
Morishige TakeshitaGraduate School of Medical Sciences, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan. m-take@adm.fukuoka-u.ac.jp.ORCID http://orcid.org/0000-0003-0267-2081
Fukuoka University · JPNational Kyushu Medical Center · JPMatsuyama Red Cross Hospital · JP

Funding

the Ministry of Education, Science and Culture of Japan No. 17K08732
6 · The paper itself

Abstract

Epstein-Barr virus (EBV)

Indexed as

Epstein-Barr Virus InfectionsLymphoma, Large B-Cell, DiffuseApoptosisB7-H1 AntigenHerpesvirus 4, HumanHumansLymphocytes, Tumor-InfiltratingMethotrexatePrognosisProto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53B7-H1 AntigenMethotrexateProto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53Diffuse large B-cell lymphomaEpstein–Barr virusProgrammed cell death 1Programmed cell death-ligand 1Tumour-infiltrating lymphocytes

Identifiers

PMID34515880
OpenAlexW3199014839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.